519148-16-4Relevant articles and documents
IMADAZOPYRIDINE COMPOUNDS HAVING 5-HT4 RECEPTOR AGONISTIC ACTIVITY AND 5-HT3 RECEPTOR ANTAGONISTIC ACTIVITY
-
Page 26-27, (2010/02/09)
This invention provides a compound of the formula (I): wherein R1 represents a hydrogen atom or a halogen atom; R2 represents a methyl group or an ethyl group; or pharmaceutically acceptable salts thereof. These compounds have 5-HT4 receptor agonistic activity and 5-HT3 receptor antagonistic activity, and thus are useful for the treatment of gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome, diabetes or the like in mammalian, especially humans. The present invention also relates to a pharmaceutical composition, a method of treatment and use, comprising the above compounds.
Imidazopyridine compounds as 5-HT4 receptor modulators
-
, (2008/06/13)
This invention provides a compound of the formula (I): 1or the pharmaceutically acceptable salts thereof wherein R1 is hydrogen, halo or alkyl; R2 and R3 are independently hydrogen, alkyl, alkenyl, alkynyl, aminoalkyl or